Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States

Cell Metabolism

Volumn 5, Issue 6, 2007, Pages 426-437

  Badman, Michael K ^a   Pissios, Pavlos ^a   Kennedy, Adam R ^a   Koukos, George ^b   Flier, Jeffrey S ^a   Maratos Flier, Eleftheria ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HUMDISEASE

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; HORMONE; KETONE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENERGY BALANCE; FATTY LIVER; GENE EXPRESSION; HORMONAL REGULATION; HYPERLIPIDEMIA; KETOACIDOSIS; KETOGENESIS; KETOGENIC DIET; LIPID METABOLISM; LIPID OXIDATION; LIVER METABOLISM; LOW CARBOHYDRATE DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; REFEEDING; REGULATORY MECHANISM;

ADENOVIRIDAE; ANIMALS; ANTILIPEMIC AGENTS; CELLS, CULTURED; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HEPATOCYTES; IMMUNOBLOTTING; KETOSIS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PPAR ALPHA; PROCETOFEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

MUS;

EID: 34249711964     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.05.002     Document Type: Article

References (29)

1. Aitman T.J., Glazier A.M., Wallace C.A., Cooper L.D., Norsworthy P.J., Wahid F.N., al Majali K.M., Trembling P.M., Mann C.J., Shoulders C.C., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21 (1999) 76-83
2. Bough K.J., and Eagles D.A. A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia 40 (1999) 138-143
3. Chakravarthy M.V., Pan Z., Zhu Y., Tordjman K., Schneider J.G., Coleman T., Turk J., and Semenkovich C.F. "New" hepatic fat activates PPAR[alpha] to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 1 (2005) 309-322
4. Febbraio M., Guy E., Coburn C., Knapp Jr. F.F., Beets A.L., Abumrad N.A., and Silverstein R.L. The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36. Mol. Cell. Biochem. 239 (2002) 193-197
5. Fu L., John L.M., Adams S.H., Yu X.X., Tomlinson E., Renz M., Williams P.M., Soriano R., Corpuz R., Moffat B., et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145 (2004) 2594-2603
6. Inaba T., Matsuda M., Shimamura M., Takei N., Terasaka N., Ando Y., Yasumo H., Koishi R., Makishima M., and Shimomura I. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J. Biol. Chem. 278 (2003) 21344-21351
7. Inagaki T., Dutchak P., Zhao G., Ding X., Gautron L., Parameswara V., Li Y., Goetz R., Mohammadi M., Esser V., et al. Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 5 (2007) 415-425 this issue
8. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., and Demeure O. Fatty acid regulation of hepatic gene transcription. J. Nutr. 135 (2005) 2503-2506
9. Kalaany N.Y., and Mangelsdorf D.J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68 (2006) 159-191
10. Kaplan R., Zhang T., Hernandez M., Gan F.X., Wright S.D., Waters M.G., and Cai T.Q. Regulation of the angiopoietin-like protein 3 gene by LXR. J. Lipid Res. 44 (2003) 136-143
11. Kennedy A.R., Pissios P., Otu H.H., Xue B., Asakura K., Furukawa N., Marino F.E., Liu F.F., Kahn B.B., Libermann T.A., and Maratos-Flier E. A high fat, ketogenic diet, induces a unique metabolic state in mice. Am. J. Physiol. Endocrinol. Metab (2007) 10.1152/ajpendo.00717.2006 Published online February 13, 2007
12. Kersten S., Seydoux J., Peters J.M., Gonzalez F.J., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103 (1999) 1489-1498
13. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., Sandusky G.E., Hammond L.J., Moyers J.S., Owens R.A., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115 (2005) 1627-1635
14. Kharitonenkov A., Wroblewski V.J., Koester A., Chen Y.F., Clutinger C.K., Tigno X.T., Hansen B.C., Shanafelt A.B., and Etgen G.J. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148 (2007) 774-781 10.1210/en.2006-1168 Published online October 26, 2006
15. Koishi R., Ando Y., Ono M., Shimamura M., Yasumo H., Fujiwara T., Horikoshi H., and Furukawa H. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30 (2002) 151-157
16. Koster A., Chao Y.B., Mosior M., Ford A., Gonzalez-DeWhitt P.A., Hale J.E., Li D., Qiu Y., Fraser C.C., Yang D.D., et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146 (2005) 4943-4950
17. Leone T.C., Weinheimer C.J., and Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 96 (1999) 7473-7478
18. Li A.C., and Glass C.K. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J. Lipid Res. 45 (2004) 2161-2173
19. Nishimura T., Nakatake Y., Konishi M., and Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 1492 (2000) 203-206
20. Petit V., Arnould L., Martin P., Monnot M.C., Pineau T., Besnard P., and Niot I. Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse. J. Lipid Res. 48 (2007) 278-287
21. Quant P.A., Tubbs P.K., and Brand M.D. Glucagon activates mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in vivo by decreasing the extent of succinylation of the enzyme. Eur. J. Biochem. 187 (1990) 169-174
22. Reddy J.K., and Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21 (2001) 193-230
23. Rodriguez J.C., Gil-Gomez G., Hegardt F.G., and Haro D. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. J. Biol. Chem. 269 (1994) 18767-18772
24. Shimamura M., Matsuda M., Kobayashi S., Ando Y., Ono M., Koishi R., Furukawa H., Makishima M., and Shimomura I. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem. Biophys. Res. Commun. 301 (2003) 604-609
25. Shimizugawa T., Ono M., Shimamura M., Yoshida K., Ando Y., Koishi R., Ueda K., Inaba T., Minekura H., Kohama T., and Furukawa H. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277 (2002) 33742-33748
26. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005) 15545-15550
27. Thio L.L., Erbayat-Altay E., Rensing N., and Yamada K.A. Leptin contributes to slower weight gain in juvenile rodents on a ketogenic diet. Pediatr. Res. 60 (2006) 413-417
28. Thumelin S., Forestier M., Girard J., and Pegorier J.P. Developmental changes in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression in rat liver, intestine and kidney. Biochem. J. 292 (1993) 493-496
29. Tomlinson E., Fu L., John L., Hultgren B., Huang X., Renz M., Stephan J.P., Tsai S.P., Powell-Braxton L., French D., and Stewart T.A. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143 (2002) 1741-1747